Clinicians from Columbia and Weill Cornell Medicine are at the forefront of pulmonary medicine and lung surgery combine leading-edge therapies with compassionate care for patients with all types and stages of lung disease. Our researchers are contributing to promising advances in acute lung injury, COPD, interstitial lung disease, and pulmonary hypertension.
Pulmonology & Lung Surgery
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
Featured Updates
On this episode of Advances in Care, Erin Welsh is joined by Dr. Lawrence Lustig, Chair of Otolaryngology–Head & Neck Surgery at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic hearing loss and after years of research his team was the first to show that gene therapies could be effective at reversing genetic hearing loss in mouse models and eventually, humans. In April 2026, the FDA approved the first ever gene therapy for genetic deafness based on the work pushed forward by Dr. Lustig.
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
